FOXO4-DRI
FOXO4 dominant-negative interfering peptide. Selectively triggers apoptosis in senescent cells by disrupting FOXO4-p53 interaction. Animal-model senolytic with strong age-reversal data in mice.
FOXO4-DRI is a senolytic peptide — it selectively kills senescent ('zombie') cells that accumulate with age and drive inflammation. The mouse data is dramatic: improved fur, kidney function, fitness in old mice. Human data is essentially nonexistent.
Not FDA approved. Pre-clinical research compound (animal-model senolytic data).
Not formally categorized in the FDA bulks lists.
Not prescribed in conventional medicine.
Who it's for
- →Researchers studying senolytics
- →Longevity-research contexts under medical guidance
- →Educational reference — limited human safety data
What to expect
- Week 1
Mouse-model markers (improved fur density, kidney function, fitness) emerged within 10 days.
- Week 4
Off-pulse. Effects in mice persisted for weeks.
- Week 8
No human long-term data exists.
How it works (mechanism)
Dominant-negative interfering peptide that disrupts the FOXO4-p53 interaction. In senescent cells, FOXO4 normally protects against p53-driven apoptosis; blocking the interaction selectively triggers death of senescent ('zombie') cells.
Dosing protocol
No standardized human dose. Mouse-model dosing pulsed at 5 mg/kg every other day for 3 doses.
Stacks well with
Side effects
When NOT to use
- ⚠Active malignancy (apoptotic effects on cells in unstable states)
- ⚠Pregnancy / nursing
- ⚠Anyone risk-averse to pre-clinical-only data
Bloodwork to monitor
- • CBC and basic metabolic panel if researching
Common mistakes
- • Treating it as a longevity 'drug' (it's pre-clinical)
- • Running long cycles instead of short pulses
- • Stacking with other experimental compounds
Educational only. User-specific dosing is between you and a qualified provider.
Frequently asked
What is FOXO4-DRI?+
Is FOXO4-DRI FDA approved?+
Is FOXO4-DRI banned by WADA?+
Are you still natty after taking FOXO4-DRI?+
Do doctors prescribe FOXO4-DRI?+
What's the typical dose of FOXO4-DRI?+
What are the side effects of FOXO4-DRI?+
How long until FOXO4-DRI starts working?+
More in Longevity
Tetrapeptide derived from epithalamin. Studied for telomerase activation and circadian / pineal support. Limited human data.
Russian-origin tetrapeptide aimed at brain aging and circadian function. Limited human data — treat as experimental.
Mitochondrial-derived peptide encoded inside mitochondrial DNA. Studied for neuroprotection, insulin sensitivity, cellular survival.
A family of short (2-4 amino acid) peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology. Tissue-specific organ-support peptides. Limited Western clinical data.